Medigus Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported revenue was USD 34.96 million compared to USD 2.39 million a year ago. Net loss was USD 3.59 million compared to net income of USD 9.79 million a year ago.

Basic loss per share from continuing operations was USD 2.25 compared to basic earnings per share from continuing operations of USD 6 a year ago. Diluted loss per share from continuing operations was USD 2.25.